To determine whether nasal intramucosal 5-fluorouracil (5-FU) injection improves outcomes after external dacryocystorhinostomy (DCR) in pediatric patients with nasolacrimal duct obstruction (NLDO).
Approach:
Study Design: Multi-center retrospective non-comparative case series review of DCR cases with intra-operative 5-FU injection performed between 2014 and 2023 on patients aged < 18 years.
Patient Review: Each case was reviewed for epiphora recurrence following surgery with 5-FU injection.
Key Findings:
SixtenpdarcwhLO19yu5Fjgbv42m
Interpretation:
Adjuvant intramucosal 5-FU demonstrated a 100% success rate of epiphora not recurring following pediatric DCR without complications.
Limitations:
Small sample size.
Retrospective study design.
Conclusion:
Intraoperative 5-FU may enhance the success of DCR in pediatric patients, particularly those at higher risk of recurrence.
Nearly 10 years of observational follow-up suggested sustained axial-length slowing, although refractive findings were less consistent and comparisons relied on statistical modeling.
This week's research makes one thing clear: who someone is before they get sick — their relationships, their partner's health, the back of their eye — is doing a lot of work medicine is only beginning to account for.
Routine dilated examinations identified peripheral retinal abnormalities across refractive groups, with higher pathology rates among patients with at least 3.00 D of myopia